2023-02419: SHINE Medical Technologies, LLC; Medical Isotope Production Facility
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
The U.S. Nuclear Regulatory Commission (NRC) has issued Supplement 1 to NUREG-2183, "Environmental Impact Statement Supplement Related to the Operating License for the SHINE Medical Isotope Production Facility." NUREG-2183 was issued October 2015. SHINE Medical Technologies, LLC (SHINE) is requesting a license to operate the Medical Isotope Production Facility (SHINE facility) in Janesville, Wisconsin.
The agency’s own summary, as published.
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →